{"gene":"ARL15","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2017,"finding":"ARL15 knockdown in differentiated murine 3T3-L1 adipocytes impaired adiponectin secretion (but not adipsin secretion or insulin action), and knockdown in preadipocytes impaired adipogenesis. GFP-tagged ARL15 localized predominantly to the Golgi with lower levels at the plasma membrane and intracellular vesicles, suggesting involvement in intracellular trafficking.","method":"Conditional siRNA knockdown in 3T3-L1 adipocytes/preadipocytes; GFP-tagging and fluorescence microscopy for subcellular localization","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean loss-of-function with specific secretion phenotype and direct localization by imaging, single lab, two orthogonal methods","pmids":["29242557"],"is_preprint":false},{"year":2021,"finding":"ARL15 directly interacts with CNNM family magnesium transporters (CNNM1-4) at their carboxyl-terminal CBS domains, co-localizes with CNNM2 in kidney cells at the ER, Golgi, and plasma membrane, and is required for complex N-glycosylation of CNNMs. ARL15 knockdown significantly increased 25Mg2+ uptake in kidney cancer cell lines, establishing ARL15 as a negative regulator of Mg2+ transport.","method":"Biochemical pulldown/co-immunoprecipitation; immunocytochemistry co-localization; in silico modeling; stable isotope 25Mg2+ uptake assay; siRNA knockdown; ARL15 overexpression","journal":"Cellular and molecular life sciences : CMLS","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical methods, functional ion transport assay, co-localization, and genetic knockdown with quantitative readout; replicated by structural studies (PMID 37449820)","pmids":["34089346"],"is_preprint":false},{"year":2022,"finding":"Active (GTP-bound) ARL15 specifically binds the MH2 domain of Smad4 and co-localizes with Smad4 at the endolysosome. This binding relieves Smad4 autoinhibition (imposed by intramolecular MH1-MH2 interaction), enabling Smad4 to interact with phosphorylated receptor-regulated Smads to form the Smad complex. Assembly of the Smad complex enhances Smad4's GAP activity toward ARL15, leading to ARL15 dissociation before nuclear translocation. ARL15 thus positively regulates TGFβ family signaling and functions as a Smad4 effector while Smad4 acts as its GAP.","method":"Co-immunoprecipitation; fluorescence co-localization; dominant-active and dominant-negative ARL15 mutants; GAP activity assay; domain mapping","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, mutant analysis, functional GAP assay, and localization experiments in a single rigorous study establishing a detailed mechanistic cycle","pmids":["35834310"],"is_preprint":false},{"year":2021,"finding":"Endogenous ARL15 is palmitoylated and localizes to the Golgi of mouse liver. Expression of palmitoylation-deficient ARL15 resulted in redistribution to the cytoplasm and mild reduction in adipogenesis-related gene expression. ARL15 undergoes Golgi translocation during adipocyte differentiation (from cis-Golgi in preadipocytes to other Golgi compartments after differentiation). Co-immunoprecipitation and mass spectrometry identified ARL6IP5 (an ER-localized protein) as an interacting partner.","method":"Palmitoylation assay; fluorescence microscopy with Golgi markers; palmitoylation-deficient mutant overexpression; co-immunoprecipitation and mass spectrometry","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct palmitoylation assay, live-cell localization with functional mutant, and Co-IP/MS for partner identification; single lab","pmids":["34779483"],"is_preprint":false},{"year":2023,"finding":"Crystal structure of the ARL15 GTPase domain in complex with the CNNM2 CBS-pair domain was solved, revealing the molecular basis for binding. ARL15 inhibits both CNNM2-mediated Mg2+ efflux and TRPM7-mediated divalent cation influx. An ARL15 binding-deficient mutant (R95A) failed to inhibit CNNM and TRPM7 transport. PRL2 (PTP4A2) competes with ARL15 for binding to CNNM, indicating antagonistic regulation. ARL15 was confirmed as a GTP-binding protein with low micromolar affinity for the CNNM CBS-pair domain.","method":"X-ray crystallography; in vitro ion transport assays; site-directed mutagenesis; binding competition assays (SPR/ITC); GTP-binding characterization","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional mutagenesis validation, in vitro transport assays, and competition binding experiments; replicated from preprint (PMID 36711628)","pmids":["37449820","36711628"],"is_preprint":false},{"year":2023,"finding":"ARL15 exhibits GTPase enzymatic activity (Km ~100 μM, Vmax ~1.47 μmole/min/μL). GTP binding affinity (Kd) is ~8-fold lower than GDP binding. SAXS analysis revealed that apo monomeric ARL15 adopts a globular shape (Dmax 6.1 nm) and undergoes conformational change upon GTP or GDP binding (Dmax ~7.6-7.7 nm), with the N-terminal region toggling open upon nucleotide binding.","method":"Spectroscopy (GTPase kinetics); equilibrium binding (Kd determination); Small Angle X-ray Scattering (SAXS); structural modeling","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic characterization and SAXS structural data from single lab; no mutagenesis to validate functional residues","pmids":["37939768"],"is_preprint":false},{"year":2025,"finding":"ARL15 localizes primarily to the Golgi and cell surface in HeLa cells. Depletion of ARL15 causes mislocalization of selective Golgi cargoes caveolin-2 and STX6. Expression of GTPase-independent dominant-negative ARL15 mutants (V80A,A86L,E122K and C22Y,C23Y) also caused mislocalization of these cargoes. ARL15 Golgi localization is dependent on palmitoylation and Arf1-dependent Golgi integrity. ARL15-depleted cells display enhanced cell spreading, adhesion strength, higher traction forces, and multiple focal adhesion points during initial cell adhesion.","method":"Stable GFP-fusion expression; fluorescence microscopy; siRNA depletion; dominant-negative mutant expression; traction force microscopy; cell adhesion assays","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cargo trafficking assay with specific readouts, dominant-negative validation, traction force microscopy; single lab with multiple orthogonal methods","pmids":["40241309"],"is_preprint":false},{"year":2023,"finding":"Global homozygous Arl15 knockout in mice is lethal postnatally and causes complete cleft palate. Arl15 knockout mouse embryonic fibroblasts show decreased cell migration. Heterozygous females show reduced fat mass and transiently lower adiponectin levels.","method":"CRISPR/Cas9 germline knockout; metabolic phenotyping; cell migration assays in MEFs","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO with defined developmental and cellular phenotypes; single lab","pmids":["37773757"],"is_preprint":false},{"year":2026,"finding":"ARL15 is triply S-acylated (palmitoylated) at three conserved N-terminal cysteine residues (Cys17, Cys22, Cys23) in HEK293T cells. Single Cys-to-Ser mutations substantially reduced S-acylation; triple mutation abolished it entirely. Loss of S-acylation disrupted membrane association of ARL15 (shown by confocal imaging and subcellular fractionation). The Golgi-localized S-acyltransferases ZDHHC7 and ZDHHC3 mediate ARL15 S-acylation in a partially redundant manner; dual inhibition caused marked reduction in S-acylation and redistribution from membranes to cytosol.","method":"Acyl-PEGyl exchange gel-shift (APE) assay; site-directed mutagenesis (Cys-to-Ser); confocal imaging; subcellular fractionation; siRNA knockdown screen; CRISPR/Cas9 gene disruption","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative biochemical acylation assay with mutagenesis, functional localization consequence, and CRISPR-validated enzyme identification using multiple orthogonal methods","pmids":["41999893"],"is_preprint":false},{"year":2026,"finding":"ARL15 knockdown in ex vivo RA synovial fibroblasts (RASF) led to downregulation of COMP (extracellular matrix stabilizer) and upregulation of adiponectin and IFN response genes (IFI6, USP18, NPTX1, MX1), and downregulation of CTGF, CD248, and PTX3, implicating ARL15 in connective tissue architecture and inflammation regulation.","method":"siRNA gene knockdown; differential transcriptomics in ex vivo RASF and in vitro MH7A cells","journal":"International journal of rheumatic diseases","confidence":"Low","confidence_rationale":"Tier 3 / Weak — transcriptomic profiling after KD; no direct biochemical mechanism established; single lab, no functional rescue experiment","pmids":["42087570"],"is_preprint":false},{"year":2019,"finding":"Overexpression of ARL15 in HUVECs under high-glucose conditions increased insulin-stimulated NO production and phosphorylation of the IR/IRS1/AKT/eNOS pathway, decreased ROS and MDA, increased SOD, and reduced ERK1/2 phosphorylation and NOX2/NOX4 expression, indicating ARL15 promotes insulin signaling and reduces oxidative stress in endothelial cells.","method":"Overexpression in HUVECs; NO measurement; ROS/MDA/SOD assays; western blot for signaling pathway components","journal":"Life sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — overexpression only with downstream pathway readouts but no direct binding or mechanism established; single lab, single approach","pmids":["30682341"],"is_preprint":false}],"current_model":"ARL15 is a small Arf-like GTPase that undergoes triple S-acylation (palmitoylation) at N-terminal cysteines by ZDHHC7/ZDHHC3, which anchors it to the Golgi and plasma membrane where it regulates vesicular cargo trafficking (caveolin-2, STX6), adiponectin secretion, and adipogenesis; in its GTP-bound active form ARL15 binds the CBS-pair domain of CNNM magnesium transporters (crystal structure solved) to inhibit both CNNM-mediated Mg2+ efflux and TRPM7-mediated divalent cation influx—competing with PRL phosphatases for CNNM binding—and also binds the MH2 domain of Smad4 at the endolysosome to relieve Smad4 autoinhibition and promote assembly of the TGFβ Smad complex, with Smad4 acting as a GAP to dissociate ARL15 before nuclear translocation."},"narrative":{"mechanistic_narrative":"ARL15 is a small Arf-like GTPase that regulates membrane trafficking, divalent cation homeostasis, and TGFβ signaling from the Golgi and endomembrane compartments [PMID:34089346, PMID:35834310, PMID:40241309]. It is a bona fide nucleotide-binding enzyme: it possesses intrinsic GTPase activity, binds GTP and GDP with distinct affinities, and undergoes an N-terminal conformational change upon nucleotide loading [PMID:37939768]. Membrane targeting is achieved through triple S-acylation at N-terminal cysteines (Cys17, Cys22, Cys23) catalyzed redundantly by the Golgi S-acyltransferases ZDHHC7 and ZDHHC3; loss of acylation redistributes ARL15 to the cytosol [PMID:41999893]. From the Golgi, ARL15 directs trafficking of selective cargoes including caveolin-2 and STX6, and its depletion alters cell adhesion, spreading, and traction force generation [PMID:40241309]. In its GTP-bound state ARL15 binds the CBS-pair domain of CNNM magnesium transporters—a structurally defined interaction (R95 critical)—to inhibit both CNNM-mediated Mg2+ efflux and TRPM7-mediated divalent cation influx, in competition with PRL phosphatases [PMID:34089346, PMID:37449820, PMID:36711628]. Active ARL15 also binds the MH2 domain of Smad4 to relieve its autoinhibition and promote Smad complex assembly, with Smad4 in turn acting as a GAP that dissociates ARL15, positioning ARL15 as a positive effector of TGFβ family signaling [PMID:35834310]. Physiologically, ARL15 supports adiponectin secretion and adipogenesis [PMID:29242557], and germline knockout in mice is postnatally lethal with complete cleft palate [PMID:37773757].","teleology":[{"year":2017,"claim":"Established the first cellular role for ARL15 by showing it is required for a specific secretory and differentiation program rather than general secretion.","evidence":"siRNA knockdown in 3T3-L1 adipocytes/preadipocytes with GFP-localization microscopy","pmids":["29242557"],"confidence":"Medium","gaps":["No molecular partner or biochemical mechanism for the secretion defect identified","Golgi localization shown by overexpressed GFP fusion only"]},{"year":2019,"claim":"Linked ARL15 to endothelial insulin signaling, raising the possibility of a metabolic signaling role.","evidence":"ARL15 overexpression in HUVECs with NO, ROS, and pathway western blot readouts","pmids":["30682341"],"confidence":"Low","gaps":["Overexpression-only with no direct binding or mechanism","No loss-of-function confirmation","Cannot distinguish direct from indirect effects on the IR/IRS1/AKT/eNOS axis"]},{"year":2021,"claim":"Identified ARL15 as a direct negative regulator of magnesium transport through binding the CBS domains of CNNM transporters, defining its first molecular partner and function.","evidence":"Co-IP/pulldown, co-localization, and 25Mg2+ uptake assays in kidney cells","pmids":["34089346"],"confidence":"High","gaps":["Nucleotide-state dependence of binding not resolved here","Mechanism by which ARL15 affects CNNM N-glycosylation unclear"]},{"year":2021,"claim":"Showed ARL15 membrane targeting depends on palmitoylation and identified ARL6IP5 as an interactor, beginning to define how ARL15 is anchored.","evidence":"Palmitoylation assay, Golgi-marker microscopy, palmitoylation-deficient mutant, and Co-IP/MS in mouse liver/adipocyte models","pmids":["34779483"],"confidence":"Medium","gaps":["Acyltransferase responsible not identified","Functional role of ARL6IP5 interaction not established"]},{"year":2022,"claim":"Defined a GTPase cycle coupling ARL15 to TGFβ signaling, showing active ARL15 relieves Smad4 autoinhibition while Smad4 serves as its GAP.","evidence":"Reciprocal Co-IP, dominant-active/negative mutants, domain mapping, and GAP activity assay","pmids":["35834310"],"confidence":"High","gaps":["GEF that activates ARL15 not identified","Connection between Smad4 effector role and trafficking/Mg2+ functions unresolved"]},{"year":2023,"claim":"Provided the structural and biophysical basis for ARL15–CNNM inhibition and revealed competition with PRL phosphatases and cross-regulation of TRPM7.","evidence":"X-ray crystallography of ARL15–CNNM2 CBS complex, in vitro transport assays, R95A mutagenesis, and competition binding","pmids":["37449820","36711628"],"confidence":"High","gaps":["How a single ARL15 simultaneously controls efflux and influx channels mechanistically unclear","In vivo relevance of PRL competition not tested"]},{"year":2023,"claim":"Characterized ARL15 as an enzymatically active GTPase that changes conformation upon nucleotide binding.","evidence":"GTPase kinetics, Kd determination, and SAXS on apo and nucleotide-bound protein","pmids":["37939768"],"confidence":"Medium","gaps":["No mutagenesis validating catalytic residues","SAXS-level resolution only for conformational change"]},{"year":2023,"claim":"Demonstrated ARL15 is essential for development, with knockout causing lethality, cleft palate, and impaired migration, linking it to morphogenesis and metabolism in vivo.","evidence":"CRISPR germline knockout mice, metabolic phenotyping, and MEF migration assays","pmids":["37773757"],"confidence":"Medium","gaps":["Molecular pathway underlying cleft palate not defined","Whether phenotypes reflect TGFβ, Mg2+, or trafficking functions unresolved"]},{"year":2025,"claim":"Defined ARL15's role in selective Golgi cargo trafficking and its consequences for cell adhesion mechanics.","evidence":"GFP-fusion microscopy, siRNA depletion, dominant-negative mutants, and traction force/adhesion assays in HeLa cells","pmids":["40241309"],"confidence":"Medium","gaps":["Mechanism linking cargo mislocalization to altered adhesion not established","Direct cargo-binding versus indirect effects not distinguished"]},{"year":2026,"claim":"Resolved the molecular basis of ARL15 membrane anchoring by identifying triple S-acylation sites and the responsible ZDHHC enzymes.","evidence":"APE acylation assay, Cys-to-Ser mutagenesis, fractionation/imaging, and siRNA/CRISPR enzyme identification in HEK293T","pmids":["41999893"],"confidence":"High","gaps":["Whether acylation is dynamically regulated not addressed","Impact of acylation on specific downstream functions (CNNM, Smad4) not tested"]},{"year":2026,"claim":"Connected ARL15 to connective tissue and inflammatory gene programs in disease-relevant synovial fibroblasts.","evidence":"siRNA knockdown with differential transcriptomics in RA synovial fibroblasts and MH7A cells","pmids":["42087570"],"confidence":"Low","gaps":["Transcriptomic association only with no direct mechanism","No functional rescue","Causality between ARL15 and COMP/IFN gene changes not established"]},{"year":null,"claim":"How ARL15's distinct molecular functions—Golgi cargo trafficking, CNNM/TRPM7 ion transport inhibition, and Smad4-effector signaling—are coordinated within a single GTPase cycle, and which upstream GEF activates it, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No GEF identified","Integration of trafficking, ion transport, and TGFβ roles not mapped onto one pathway"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[4,5]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,4,2]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,3,6,8]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,6]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[2]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,3]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[6,0]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[8]}],"complexes":[],"partners":["CNNM1","CNNM2","CNNM3","CNNM4","SMAD4","ARL6IP5","STX6"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NXU5","full_name":"ADP-ribosylation factor-like protein 15","aliases":["ADP-ribosylation factor-related protein 2","ARF-related protein 2"],"length_aa":204,"mass_kda":22.9,"function":"","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q9NXU5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARL15","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ARL15","total_profiled":1310},"omim":[],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Microtubules","reliability":"Approved"},{"location":"Primary cilium","reliability":"Approved"},{"location":"Cytokinetic bridge","reliability":"Additional"},{"location":"Mitotic spindle","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARL15"},"hgnc":{"alias_symbol":["FLJ20051"],"prev_symbol":["ARFRP2"]},"alphafold":{"accession":"Q9NXU5","domains":[{"cath_id":"3.40.50.300","chopping":"29-202","consensus_level":"high","plddt":94.209,"start":29,"end":202}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NXU5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NXU5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NXU5-F1-predicted_aligned_error_v6.png","plddt_mean":88.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARL15","jax_strain_url":"https://www.jax.org/strain/search?query=ARL15"},"sequence":{"accession":"Q9NXU5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NXU5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NXU5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NXU5"}},"corpus_meta":[{"pmid":"20011104","id":"PMC_20011104","title":"A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20011104","citation_count":143,"is_preprint":false},{"pmid":"23918589","id":"PMC_23918589","title":"A genome-wide association study reveals ARL15, a novel non-HLA susceptibility gene for rheumatoid arthritis in North Indians.","date":"2013","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/23918589","citation_count":38,"is_preprint":false},{"pmid":"29242557","id":"PMC_29242557","title":"The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29242557","citation_count":28,"is_preprint":false},{"pmid":"34089346","id":"PMC_34089346","title":"ARL15 modulates magnesium homeostasis through N-glycosylation of CNNMs.","date":"2021","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/34089346","citation_count":25,"is_preprint":false},{"pmid":"35834310","id":"PMC_35834310","title":"Arl15 upregulates the TGFβ family signaling by promoting the assembly of the Smad-complex.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35834310","citation_count":16,"is_preprint":false},{"pmid":"26722494","id":"PMC_26722494","title":"Association of the ARL15 rs6450176 SNP and serum lipid levels in the Jing and Han populations.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26722494","citation_count":16,"is_preprint":false},{"pmid":"34779483","id":"PMC_34779483","title":"Palmitoylated small GTPase ARL15 is translocated within Golgi network during adipogenesis.","date":"2021","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/34779483","citation_count":15,"is_preprint":false},{"pmid":"37449820","id":"PMC_37449820","title":"Structural insights into regulation of CNNM-TRPM7 divalent cation uptake by the small GTPase ARL15.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37449820","citation_count":11,"is_preprint":false},{"pmid":"30682341","id":"PMC_30682341","title":"ARL15 overexpression attenuates high glucose-induced impairment of insulin signaling and oxidative stress in human umbilical vein endothelial cells.","date":"2019","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30682341","citation_count":11,"is_preprint":false},{"pmid":"24688318","id":"PMC_24688318","title":"Association study of ARL15 and CDH13 with T2DM in a Han Chinese population.","date":"2014","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24688318","citation_count":6,"is_preprint":false},{"pmid":"34187973","id":"PMC_34187973","title":"Correlation between an intronic SNP genotype and ARL15 level in rheumatoid arthritis.","date":"2021","source":"Journal of genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34187973","citation_count":5,"is_preprint":false},{"pmid":"37939768","id":"PMC_37939768","title":"ARL15, a GTPase implicated in rheumatoid arthritis, potentially repositions its truncated N-terminus as a function of guanine nucleotide binding.","date":"2023","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/37939768","citation_count":4,"is_preprint":false},{"pmid":"29382430","id":"PMC_29382430","title":"[Genetic polymorphisms of ARL15 and HLA-DMA are associated with rheumatoid arthritis in Han population from northwest China].","date":"2017","source":"Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29382430","citation_count":3,"is_preprint":false},{"pmid":"36711628","id":"PMC_36711628","title":"Structural insights into regulation of TRPM7 divalent cation uptake by the small GTPase ARL15.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36711628","citation_count":2,"is_preprint":false},{"pmid":"37351048","id":"PMC_37351048","title":"Study Protocol for the Interactions between Dietary Patterns and ARL15 and ADIPOQ Genes Polymorphisms on Cardiometabolic Risk Factors.","date":"2023","source":"International journal of preventive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37351048","citation_count":2,"is_preprint":false},{"pmid":"37718516","id":"PMC_37718516","title":"ARL15 and its Multiple Disease Association: Emerging Functions and Potential Therapeutic Application.","date":"2024","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/37718516","citation_count":1,"is_preprint":false},{"pmid":"40336772","id":"PMC_40336772","title":"ARL15 Gene Variant rs255758 Provides Susceptibility to Rheumatoid Arthritis in Northwest Indian Population.","date":"2025","source":"International journal of applied & basic medical research","url":"https://pubmed.ncbi.nlm.nih.gov/40336772","citation_count":1,"is_preprint":false},{"pmid":"39865127","id":"PMC_39865127","title":"Interactions between DASH-style diet and ADIPOQ and ARL15 genes polymorphisms on blood pressure and central obesity in Iranian adults.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39865127","citation_count":1,"is_preprint":false},{"pmid":"40241309","id":"PMC_40241309","title":"Golgi Localized Arl15 Regulates Cargo Transport and Cell Adhesion.","date":"2025","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/40241309","citation_count":0,"is_preprint":false},{"pmid":"37773757","id":"PMC_37773757","title":"Cleft palate and minor metabolic disturbances in a mouse global Arl15 gene knockout.","date":"2023","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37773757","citation_count":0,"is_preprint":false},{"pmid":"41999893","id":"PMC_41999893","title":"S-acylation and membrane localization of the small GTPase ARL15 are mediated by the Golgi S-acyltransferases ZDHHC7 and ZDHHC3.","date":"2026","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41999893","citation_count":0,"is_preprint":false},{"pmid":"42087570","id":"PMC_42087570","title":"Dissecting ARL15 Function in Rheumatoid Arthritis: Insights From Ex Vivo and in Vitro Synovial Fibroblast Models.","date":"2026","source":"International journal of rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/42087570","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.30.662131","title":"Dissecting  <i>ARL15</i>  Function in Rheumatoid Arthritis: Insights from  <i>Ex Vivo</i>  and  <i>In Vitro</i>  Synovial Fibroblast Models","date":"2025-07-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.30.662131","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13708,"output_tokens":3450,"usd":0.046437,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10955,"output_tokens":3644,"usd":0.072938,"stage2_stop_reason":"end_turn"},"total_usd":0.119375,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"ARL15 knockdown in differentiated murine 3T3-L1 adipocytes impaired adiponectin secretion (but not adipsin secretion or insulin action), and knockdown in preadipocytes impaired adipogenesis. GFP-tagged ARL15 localized predominantly to the Golgi with lower levels at the plasma membrane and intracellular vesicles, suggesting involvement in intracellular trafficking.\",\n      \"method\": \"Conditional siRNA knockdown in 3T3-L1 adipocytes/preadipocytes; GFP-tagging and fluorescence microscopy for subcellular localization\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean loss-of-function with specific secretion phenotype and direct localization by imaging, single lab, two orthogonal methods\",\n      \"pmids\": [\"29242557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ARL15 directly interacts with CNNM family magnesium transporters (CNNM1-4) at their carboxyl-terminal CBS domains, co-localizes with CNNM2 in kidney cells at the ER, Golgi, and plasma membrane, and is required for complex N-glycosylation of CNNMs. ARL15 knockdown significantly increased 25Mg2+ uptake in kidney cancer cell lines, establishing ARL15 as a negative regulator of Mg2+ transport.\",\n      \"method\": \"Biochemical pulldown/co-immunoprecipitation; immunocytochemistry co-localization; in silico modeling; stable isotope 25Mg2+ uptake assay; siRNA knockdown; ARL15 overexpression\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical methods, functional ion transport assay, co-localization, and genetic knockdown with quantitative readout; replicated by structural studies (PMID 37449820)\",\n      \"pmids\": [\"34089346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Active (GTP-bound) ARL15 specifically binds the MH2 domain of Smad4 and co-localizes with Smad4 at the endolysosome. This binding relieves Smad4 autoinhibition (imposed by intramolecular MH1-MH2 interaction), enabling Smad4 to interact with phosphorylated receptor-regulated Smads to form the Smad complex. Assembly of the Smad complex enhances Smad4's GAP activity toward ARL15, leading to ARL15 dissociation before nuclear translocation. ARL15 thus positively regulates TGFβ family signaling and functions as a Smad4 effector while Smad4 acts as its GAP.\",\n      \"method\": \"Co-immunoprecipitation; fluorescence co-localization; dominant-active and dominant-negative ARL15 mutants; GAP activity assay; domain mapping\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, mutant analysis, functional GAP assay, and localization experiments in a single rigorous study establishing a detailed mechanistic cycle\",\n      \"pmids\": [\"35834310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Endogenous ARL15 is palmitoylated and localizes to the Golgi of mouse liver. Expression of palmitoylation-deficient ARL15 resulted in redistribution to the cytoplasm and mild reduction in adipogenesis-related gene expression. ARL15 undergoes Golgi translocation during adipocyte differentiation (from cis-Golgi in preadipocytes to other Golgi compartments after differentiation). Co-immunoprecipitation and mass spectrometry identified ARL6IP5 (an ER-localized protein) as an interacting partner.\",\n      \"method\": \"Palmitoylation assay; fluorescence microscopy with Golgi markers; palmitoylation-deficient mutant overexpression; co-immunoprecipitation and mass spectrometry\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct palmitoylation assay, live-cell localization with functional mutant, and Co-IP/MS for partner identification; single lab\",\n      \"pmids\": [\"34779483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Crystal structure of the ARL15 GTPase domain in complex with the CNNM2 CBS-pair domain was solved, revealing the molecular basis for binding. ARL15 inhibits both CNNM2-mediated Mg2+ efflux and TRPM7-mediated divalent cation influx. An ARL15 binding-deficient mutant (R95A) failed to inhibit CNNM and TRPM7 transport. PRL2 (PTP4A2) competes with ARL15 for binding to CNNM, indicating antagonistic regulation. ARL15 was confirmed as a GTP-binding protein with low micromolar affinity for the CNNM CBS-pair domain.\",\n      \"method\": \"X-ray crystallography; in vitro ion transport assays; site-directed mutagenesis; binding competition assays (SPR/ITC); GTP-binding characterization\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional mutagenesis validation, in vitro transport assays, and competition binding experiments; replicated from preprint (PMID 36711628)\",\n      \"pmids\": [\"37449820\", \"36711628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARL15 exhibits GTPase enzymatic activity (Km ~100 μM, Vmax ~1.47 μmole/min/μL). GTP binding affinity (Kd) is ~8-fold lower than GDP binding. SAXS analysis revealed that apo monomeric ARL15 adopts a globular shape (Dmax 6.1 nm) and undergoes conformational change upon GTP or GDP binding (Dmax ~7.6-7.7 nm), with the N-terminal region toggling open upon nucleotide binding.\",\n      \"method\": \"Spectroscopy (GTPase kinetics); equilibrium binding (Kd determination); Small Angle X-ray Scattering (SAXS); structural modeling\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic characterization and SAXS structural data from single lab; no mutagenesis to validate functional residues\",\n      \"pmids\": [\"37939768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ARL15 localizes primarily to the Golgi and cell surface in HeLa cells. Depletion of ARL15 causes mislocalization of selective Golgi cargoes caveolin-2 and STX6. Expression of GTPase-independent dominant-negative ARL15 mutants (V80A,A86L,E122K and C22Y,C23Y) also caused mislocalization of these cargoes. ARL15 Golgi localization is dependent on palmitoylation and Arf1-dependent Golgi integrity. ARL15-depleted cells display enhanced cell spreading, adhesion strength, higher traction forces, and multiple focal adhesion points during initial cell adhesion.\",\n      \"method\": \"Stable GFP-fusion expression; fluorescence microscopy; siRNA depletion; dominant-negative mutant expression; traction force microscopy; cell adhesion assays\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cargo trafficking assay with specific readouts, dominant-negative validation, traction force microscopy; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"40241309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Global homozygous Arl15 knockout in mice is lethal postnatally and causes complete cleft palate. Arl15 knockout mouse embryonic fibroblasts show decreased cell migration. Heterozygous females show reduced fat mass and transiently lower adiponectin levels.\",\n      \"method\": \"CRISPR/Cas9 germline knockout; metabolic phenotyping; cell migration assays in MEFs\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO with defined developmental and cellular phenotypes; single lab\",\n      \"pmids\": [\"37773757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"ARL15 is triply S-acylated (palmitoylated) at three conserved N-terminal cysteine residues (Cys17, Cys22, Cys23) in HEK293T cells. Single Cys-to-Ser mutations substantially reduced S-acylation; triple mutation abolished it entirely. Loss of S-acylation disrupted membrane association of ARL15 (shown by confocal imaging and subcellular fractionation). The Golgi-localized S-acyltransferases ZDHHC7 and ZDHHC3 mediate ARL15 S-acylation in a partially redundant manner; dual inhibition caused marked reduction in S-acylation and redistribution from membranes to cytosol.\",\n      \"method\": \"Acyl-PEGyl exchange gel-shift (APE) assay; site-directed mutagenesis (Cys-to-Ser); confocal imaging; subcellular fractionation; siRNA knockdown screen; CRISPR/Cas9 gene disruption\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative biochemical acylation assay with mutagenesis, functional localization consequence, and CRISPR-validated enzyme identification using multiple orthogonal methods\",\n      \"pmids\": [\"41999893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"ARL15 knockdown in ex vivo RA synovial fibroblasts (RASF) led to downregulation of COMP (extracellular matrix stabilizer) and upregulation of adiponectin and IFN response genes (IFI6, USP18, NPTX1, MX1), and downregulation of CTGF, CD248, and PTX3, implicating ARL15 in connective tissue architecture and inflammation regulation.\",\n      \"method\": \"siRNA gene knockdown; differential transcriptomics in ex vivo RASF and in vitro MH7A cells\",\n      \"journal\": \"International journal of rheumatic diseases\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — transcriptomic profiling after KD; no direct biochemical mechanism established; single lab, no functional rescue experiment\",\n      \"pmids\": [\"42087570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Overexpression of ARL15 in HUVECs under high-glucose conditions increased insulin-stimulated NO production and phosphorylation of the IR/IRS1/AKT/eNOS pathway, decreased ROS and MDA, increased SOD, and reduced ERK1/2 phosphorylation and NOX2/NOX4 expression, indicating ARL15 promotes insulin signaling and reduces oxidative stress in endothelial cells.\",\n      \"method\": \"Overexpression in HUVECs; NO measurement; ROS/MDA/SOD assays; western blot for signaling pathway components\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — overexpression only with downstream pathway readouts but no direct binding or mechanism established; single lab, single approach\",\n      \"pmids\": [\"30682341\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARL15 is a small Arf-like GTPase that undergoes triple S-acylation (palmitoylation) at N-terminal cysteines by ZDHHC7/ZDHHC3, which anchors it to the Golgi and plasma membrane where it regulates vesicular cargo trafficking (caveolin-2, STX6), adiponectin secretion, and adipogenesis; in its GTP-bound active form ARL15 binds the CBS-pair domain of CNNM magnesium transporters (crystal structure solved) to inhibit both CNNM-mediated Mg2+ efflux and TRPM7-mediated divalent cation influx—competing with PRL phosphatases for CNNM binding—and also binds the MH2 domain of Smad4 at the endolysosome to relieve Smad4 autoinhibition and promote assembly of the TGFβ Smad complex, with Smad4 acting as a GAP to dissociate ARL15 before nuclear translocation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARL15 is a small Arf-like GTPase that regulates membrane trafficking, divalent cation homeostasis, and TGFβ signaling from the Golgi and endomembrane compartments [#1, #2, #6]. It is a bona fide nucleotide-binding enzyme: it possesses intrinsic GTPase activity, binds GTP and GDP with distinct affinities, and undergoes an N-terminal conformational change upon nucleotide loading [#5]. Membrane targeting is achieved through triple S-acylation at N-terminal cysteines (Cys17, Cys22, Cys23) catalyzed redundantly by the Golgi S-acyltransferases ZDHHC7 and ZDHHC3; loss of acylation redistributes ARL15 to the cytosol [#8]. From the Golgi, ARL15 directs trafficking of selective cargoes including caveolin-2 and STX6, and its depletion alters cell adhesion, spreading, and traction force generation [#6]. In its GTP-bound state ARL15 binds the CBS-pair domain of CNNM magnesium transporters—a structurally defined interaction (R95 critical)—to inhibit both CNNM-mediated Mg2+ efflux and TRPM7-mediated divalent cation influx, in competition with PRL phosphatases [#1, #4]. Active ARL15 also binds the MH2 domain of Smad4 to relieve its autoinhibition and promote Smad complex assembly, with Smad4 in turn acting as a GAP that dissociates ARL15, positioning ARL15 as a positive effector of TGFβ family signaling [#2]. Physiologically, ARL15 supports adiponectin secretion and adipogenesis [#0], and germline knockout in mice is postnatally lethal with complete cleft palate [#7].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2017,\n      \"claim\": \"Established the first cellular role for ARL15 by showing it is required for a specific secretory and differentiation program rather than general secretion.\",\n      \"evidence\": \"siRNA knockdown in 3T3-L1 adipocytes/preadipocytes with GFP-localization microscopy\",\n      \"pmids\": [\"29242557\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No molecular partner or biochemical mechanism for the secretion defect identified\", \"Golgi localization shown by overexpressed GFP fusion only\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked ARL15 to endothelial insulin signaling, raising the possibility of a metabolic signaling role.\",\n      \"evidence\": \"ARL15 overexpression in HUVECs with NO, ROS, and pathway western blot readouts\",\n      \"pmids\": [\"30682341\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Overexpression-only with no direct binding or mechanism\", \"No loss-of-function confirmation\", \"Cannot distinguish direct from indirect effects on the IR/IRS1/AKT/eNOS axis\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified ARL15 as a direct negative regulator of magnesium transport through binding the CBS domains of CNNM transporters, defining its first molecular partner and function.\",\n      \"evidence\": \"Co-IP/pulldown, co-localization, and 25Mg2+ uptake assays in kidney cells\",\n      \"pmids\": [\"34089346\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nucleotide-state dependence of binding not resolved here\", \"Mechanism by which ARL15 affects CNNM N-glycosylation unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed ARL15 membrane targeting depends on palmitoylation and identified ARL6IP5 as an interactor, beginning to define how ARL15 is anchored.\",\n      \"evidence\": \"Palmitoylation assay, Golgi-marker microscopy, palmitoylation-deficient mutant, and Co-IP/MS in mouse liver/adipocyte models\",\n      \"pmids\": [\"34779483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acyltransferase responsible not identified\", \"Functional role of ARL6IP5 interaction not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined a GTPase cycle coupling ARL15 to TGFβ signaling, showing active ARL15 relieves Smad4 autoinhibition while Smad4 serves as its GAP.\",\n      \"evidence\": \"Reciprocal Co-IP, dominant-active/negative mutants, domain mapping, and GAP activity assay\",\n      \"pmids\": [\"35834310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEF that activates ARL15 not identified\", \"Connection between Smad4 effector role and trafficking/Mg2+ functions unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided the structural and biophysical basis for ARL15–CNNM inhibition and revealed competition with PRL phosphatases and cross-regulation of TRPM7.\",\n      \"evidence\": \"X-ray crystallography of ARL15–CNNM2 CBS complex, in vitro transport assays, R95A mutagenesis, and competition binding\",\n      \"pmids\": [\"37449820\", \"36711628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single ARL15 simultaneously controls efflux and influx channels mechanistically unclear\", \"In vivo relevance of PRL competition not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Characterized ARL15 as an enzymatically active GTPase that changes conformation upon nucleotide binding.\",\n      \"evidence\": \"GTPase kinetics, Kd determination, and SAXS on apo and nucleotide-bound protein\",\n      \"pmids\": [\"37939768\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mutagenesis validating catalytic residues\", \"SAXS-level resolution only for conformational change\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated ARL15 is essential for development, with knockout causing lethality, cleft palate, and impaired migration, linking it to morphogenesis and metabolism in vivo.\",\n      \"evidence\": \"CRISPR germline knockout mice, metabolic phenotyping, and MEF migration assays\",\n      \"pmids\": [\"37773757\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular pathway underlying cleft palate not defined\", \"Whether phenotypes reflect TGFβ, Mg2+, or trafficking functions unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined ARL15's role in selective Golgi cargo trafficking and its consequences for cell adhesion mechanics.\",\n      \"evidence\": \"GFP-fusion microscopy, siRNA depletion, dominant-negative mutants, and traction force/adhesion assays in HeLa cells\",\n      \"pmids\": [\"40241309\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking cargo mislocalization to altered adhesion not established\", \"Direct cargo-binding versus indirect effects not distinguished\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Resolved the molecular basis of ARL15 membrane anchoring by identifying triple S-acylation sites and the responsible ZDHHC enzymes.\",\n      \"evidence\": \"APE acylation assay, Cys-to-Ser mutagenesis, fractionation/imaging, and siRNA/CRISPR enzyme identification in HEK293T\",\n      \"pmids\": [\"41999893\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether acylation is dynamically regulated not addressed\", \"Impact of acylation on specific downstream functions (CNNM, Smad4) not tested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Connected ARL15 to connective tissue and inflammatory gene programs in disease-relevant synovial fibroblasts.\",\n      \"evidence\": \"siRNA knockdown with differential transcriptomics in RA synovial fibroblasts and MH7A cells\",\n      \"pmids\": [\"42087570\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Transcriptomic association only with no direct mechanism\", \"No functional rescue\", \"Causality between ARL15 and COMP/IFN gene changes not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ARL15's distinct molecular functions—Golgi cargo trafficking, CNNM/TRPM7 ion transport inhibition, and Smad4-effector signaling—are coordinated within a single GTPase cycle, and which upstream GEF activates it, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No GEF identified\", \"Integration of trafficking, ion transport, and TGFβ roles not mapped onto one pathway\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 4, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 3, 6, 8]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 6]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [6, 0]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CNNM1\", \"CNNM2\", \"CNNM3\", \"CNNM4\", \"SMAD4\", \"ARL6IP5\", \"STX6\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":7,"faith_total":7,"faith_pct":100.0}}